Butterfly Network's stock was largely unchanged following Q2 2026 results, reflecting a balanced mix of steady execution in Embedded partnerships and gradual software adoption without clear upside surprises.
- Revenue, gross margins, and adjusted EBITDA came in near the top of prior guidance; full year guidance was raised modestly.
- Embedded partnerships reached a total of 11 with two new agreements, broadening applications in brain-computer interfaces and women's health wearables.
- Point-of-care ultrasound (POCUS) business advanced with six new enterprise software deals for Compass AI, growing the pipeline fivefold since last year.
- Provisional authorization secured to sell to the entire VA system; broader U.S. government sales opportunities are developing.
- Despite management’s positive framing, the market viewed progress as incremental rather than breakthrough, leading to a flat share price reaction of +0.1%.
Community Discussion